Hepatocellular Carcinoma Imaging - Medscape Transpl. MRI proton density fat fraction for estimation of tumor grade in A partial or complete hyperintense rim surrounding the nodule on PVP and/or DP defined the term enhancing capsule. Selective or superselective catheterization of the hepatic arterial branches supplying HCC is performed to maximize delivery of drug-eluting microspheres in the tumor, and thereby minimizing the exposure of normal hepatic parenchyma. Song, J. S., Choi, E. J., Hwang, S. B., Hwang, H. P. & Choi, H. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI. body habitus), T1-weighted gradient echo sequence (3D preferable), T2-weighted (with and without fat saturation), 23 mL/s of extracellular gadolinium chelate that does not have dominant biliary excretion, Preferably resulting in vendor-recommended total dose, Mandatory dynamic phases on contrast enhanced MRI (comments describe typical hallmark image features), The use of a bolus tracking method for timing contrast arrival for late arterial phase imaging is preferable. The wash-in of the HCC lesions was significantly higher (P<0.001) after administration of gadoteric acid (0.9; IQR: 0.61.5) than after gadoxetic acid (0.4; IQR: 0.10.7). The resulting vascular pattern characterized by arterial contrast uptake (wash-in) followed by wash-out in the venous phases allowed defining the non-invasive diagnostic criteria for HCC4. The elevated T2 signal in a focal lesion can be useful to reliably differentiate HCC from dysplastic nodules. 1 Introduction. This is distinctive from cholangiocarcinoma, a tumor that invades along the outer margins of the veins and occludes the vessels by constriction. The target HCC lesions were marked by the study coordinator and nodule diameter was measured as the longest diameter on HBP images on gadoxetic acid-enhanced MRI. During the portal venous phase (PVP) and delayed phase (DP), gadoteric acid-enhanced MRI showed a significantly higher overall image quality (P=0.041 and 0.008, respectively). The PVP was defined as the postcontrast phase in which portal veins are fully enhanced, the hepatic veins are enhanced by antegrade flow and the liver parenchyma is at peak enhancement. Kalb B, Becker-Weidman DJ, Chundru S, et al. Reason. Intervent. Figures(1a3a) demonstrates higher image quality, lower artifacts as well as the higher conspicuity of HCC lesions during the arterial phase after administration of the extracellular contrast agent gadoteric acid than with the hepatocyte-specific contrast agent gadoxetic acid (1b3b). Special stains for HCC confirmed the diagnosis in the surgical specimen. There is no washout on delayed phase imaging, using conventional extracellular GBCAs because supply from the portal venous system remains comparable with the adjacent liver (Fig. There are various forms of direct ablation that includes intralesional injection of toxic agents (chemicals, radioactive isotopes, or chemotherapeutic drugs), application of an energy source capable of producing heat (such as radiofrequency and microwave), and also the use of tumor cooling and freezing (cryotherapy). Willatt JM, Hussain HK, Adusumilli S, Marrero JA. European Association for the Study of the Liver (EASL) and European Organization for Research and Treatment of Cancer (EORTC) prepared guidelines for screening, follow-up and diagnosis of HCC to facilitate decision making and optimize both diagnostic and . arrowheads) compared with the in-phase images (f, 3) (7, 13). European Association for the Study of the Liver. arrowheads), consistent with internal lipid within the tumor, a feature characteristic of HCC. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53 Lencioni R, Llovet JM. https://doi.org/10.1016/j.biopha.2016.10.078, https://doi.org/10.1016/S0140-6736(18)30010-2, https://doi.org/10.1016/j.ejrad.2018.01.025, https://doi.org/10.1111/j.1432-2277.2008.00793.x, https://doi.org/10.1007/s00330-015-3900-3, https://doi.org/10.1007/s00261-011-9685-1, https://doi.org/10.1016/j.jhep.2018.03.019, https://doi.org/10.1097/RLI.0b013e3181caea5b, https://doi.org/10.1007/s12072-013-9505-5, https://doi.org/10.3978/j.issn.2218-676X.2014.07.01, https://doi.org/10.1097/RCT.0b013e3181e1a88e, https://doi.org/10.1007/s00330-018-5559-z, https://doi.org/10.1088/0031-9155/44/12/403, https://doi.org/10.1002/(sici)1522-2594(199905)41:5%3c1009::aid-mrm21%3e3.0.co;2-4, https://doi.org/10.1148/radiol.2313021113, https://doi.org/10.1007/s00261-018-1730-x, https://doi.org/10.1148/radiol.2262011593, http://creativecommons.org/licenses/by/4.0/. When a focus of HCC develops within a dysplastic nodule, a mildly elevated signal may be observed on T2-weighted images, representing the focus of HCC within the low density dysplastic nodule, and has been described as a nodule in nodule appearance. Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK. Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide ().Although the prognosis of HCC patients has improved with advances in imaging and surgical techniques, the high rates of intrahepatic recurrence after surgical resection still remain a major challenge, and two thirds of the patients experience recurrence within 5 years (2, 3). This case demonstrates the value of MRI when used as a primary diagnostic modality for liver lesions, and HCC in particular. J. Magn. CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma An increased three- to six-months interval imaging frequency has been suggested (20). Hepatocellular carcinoma (HCC) is a major worldwide health concern; it is the sixth most common cancer and third leading cause of overall cancer-related mortality. Myung SJ, Yoon JH, Kim KM, et al. Progress of MRI Radiomics in Hepatocellular Carcinoma MRI features of histologic subtypes of hepatocellular carcinoma arrow), which shows avid enhancement on the arterial phase (b, Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. The mean longest diameter of the HCC lesions measured in the hepatobiliary phase (HBP) was 42mm (range 17124mm). Hepatocellular carcinoma (HCC) is a malignancy with variable biologic aggressiveness based on the tumor grade, presence or absence of vascular invasion, and pathologic and molecular classification. First, this is a single-center prospective study including patients with established HCC diagnosis in liver cirrhosis with a clinical indication for pretherapeutic liver MRI prior to liver surgery. J. Roentgenol. All of these techniques induce eventual tissue necrosis. Imaging of HCC. It has been shown that this enhancing halo may persist around the embolized treatment cavity for several months, and this finding should not be mistaken for tumor recurrence (4648). A malignant venous thrombus may be relatively less conspicuous on Gd-EOB-DTPA because the adjacent liver may enhance to a greater degree than the tumor thrombus effectively diminishing the tumor thrombus conspicuity. Hepatocellular carcinoma(HCC) is the sixth most common malignant tumor worldwide in terms of incidence, and it ranks third in terms of mortality rate (1, 2), accounting for approximately 90% of primary liver cancer ().In China, HCC is the second leading cause of cancer-related deaths ().The development of HCC is a multistage and multifactorial process, and HCC is heterogeneous . When iron is present in regenerative nodules, susceptibility effects can result in decreased signal intensity on both T1-and T2-weighted images. The Liver Imaging-Reporting and Data System (LI-RADS) is a new method of reporting endorsed by the American College of Radiology to formulate a standardized terminology and reporting structure for evaluation of lesions identified in patients with CLD. A 85-year-old man with hepatitis C infection presents with liver mass. Objective: This study aimed to determine whether hepatocellular carcinoma (HCC) risk and time to HCC development differ according to hepatobiliary magnetic resonance imaging (MRI) findings among people at risk for developing HCC. Magn. 8600 Rockville Pike Portal venous phase and delayed phase images were acquired 50s, 90s and 120s after contrast agent administration. Hepatocellular carcinoma (HCC) remains threatening human health worldwide significantly. Purpose To clarify the imaging characteristics of P53-mutated HCC at dynamic CT and gadoxetic acid-enhanced MRI that are correlated with its clinical features, pathologic findings, and prognosis. The authors declared no conflicts of interest. T.D. The variant types of HCC may not share its typical imaging characteristics. Gadolinium-enhanced arterial phase image (c) shows diffuse, nonuniform enhancement throughout the right hepatic lobe, but without a focal lesion. During the PVP, an enhancing capsule (Fig. Parallel acquisition techniques for accelerated volumetric interpolated breath-hold examination magnetic resonance imaging of the upper abdomen: Assessment of image quality and lesion conspicuity. Note incidental postsurgical changes in anterior segment VIII. Macro-vascular invasion most commonly involves the portal system and less commonly the hepatic veins. These results are in line with those obtained by Min et al. MRI examinations were performed on a single 3T MR system (Magnetom Skyra; Siemens Healthcare, Erlangen, Germany) using an 18-element body matrix coil and a 32-element spine coil. HHS Vulnerability Disclosure, Help In the DP portal and hepatic veins as well as liver parenchyma are enhanced but less than in PVP. 3, 383390. Radiol. Some studies have suggested a lower sensitivity for dysplastic nodules, small HCC, and infiltrative-HCC compared with MRI (Fig. In fact, on HSCA-enhanced MRI early contrast uptake into the hepatocyte during the DP might exaggerate washout resulting in some studies in even significantly higher rates of (pseudo)washout. FOIA Article G-EOB-DTPA has been advocated for use in the diagnosis of HCC, with the concept that carcinoma cells will not express the anion-transporting peptide to accumulate the gadolinium agent; tumor should then present as a focus of hypointense signal against the remainder of the hepatic parenchyma that expresses this transporter and takes up the Gd-EOB-DTPA. PubMed MRI Assessment of Hepatocellular Carcinoma after Local-Regional Therapy The results of qualitative analysis of overall image quality, artifacts and lesion conspicuity for both contrast agents and throughout the different perfusion phases are reported in Table 2. ObjectiveTo develop and validate a radiomic nomogram for individualized prediction of hepatocellular carcinoma (HCC) in HBV cirrhosis patients based on baseline magnetic resonance imaging examinations and clinical data.Methods364 patients with HBV cirrhosis from five hospitals were assigned to the training, internal validation, external validation-1 or external validation-2 cohort. From the Departments of Medical Imaging (H.A.T., B.K., S.C., P.S., J.C., D.R.M. Matsui, O. et al. In consequence metric data are given as median and interquartile range (2575th-percentiles) and the paired Wilcoxon signed-rank test was used. The repeated use of CT for screening raises concerns with regard to cumulative X-ray dose effects. GBCA-enhanced multiphase MRI (with an accurately timed arterial phase) is an extremely sensitive and specific imaging technique for HCC screening. Hepatocellular carcinoma (HCC) is the sixth most common neoplasm and the third biggest cause of cancer-related deaths worldwide, with an estimated 900,000 new cases and 830,000 deaths in 2020 (1,2).Recent progress in systemic chemotherapy for advanced HCC, such as immune checkpoint inhibitors (ICIs) and molecular targeted agents, has improved patient outcomes (3-7). Dietrich, O., Raya, J., Reeder, S., Reiser, M. & Schoenberg, S. Measurement of signal-to-noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filters. This article reviews the molecular cytogenetics, pathology, imaging features, and management of this relatively rare tumor. Non-peripheral washout was more frequent using ECA-enhanced MRI, however the difference was insignificant. The findings suggestive of, but not diagnostic of either a benign lesion or HCC are categorized as LR2 and LR4, respectively. Federal government websites often end in .gov or .mil. In a separate study, mosaic appearance of tumor was. Imaging 29, 636640. https://doi.org/10.1148/radiol.11101840 (2011). Infiltrative hepatocellular carcinoma | Radiology Reference Article Substantial interobserver agreement was observed during the delayed phase regarding non-peripheral washout (0.646 [95% CI: 0.0111] for gadoteric acid and 0.617 [95% CI: 0.1331] for gadoxetic acid) and enhancing capsule (0.0.642 [95% CI: 0.2471.0] for gadoteric acid and 0.649 [95% CI: 0.3410.957] for gadoxetic acid), as well as for detection of arterial phase hyperenhancement during the late arterial phase of gadoteric acid-enhanced MRI (0.623 [95% CI: 0.161]). Overall image quality of the different phases was assessed based on the definitions proposed by LI-RADS v201817. All . Figures (a,b) demonstrates the stronger wash-in after administration of the extracellular contrast agent gadoteric acid (a) than with the hepatocyte-specific contrast agent gadoxetic acid (b). J. Vasc. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. The patient was reimaged three months after chemoembolization to assess response to treatment; precontrast (d), arterial phase (e), and delayed phase (f) images show no abnormal arterial enhancing tissue within the treatment site to suggest residual disease (e, f, Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR. Abdom. https://doi.org/10.1148/radiol.2313021113 (2004). https://doi.org/10.1088/0031-9155/44/12/403 (1999). Complementary to conventional MRI, a lesion on DWI is suspicious for HCC when it shows sustained, elevated signal relative to the surrounding liver parenchyma with increasing b factors (b=50, 400, and 800 s/mm2) and a nearly equivalent or lower apparent diffusion coefficient compared with the background parenchyma on the ADC map (24, 25). https://doi.org/10.1007/s00261-011-9685-1 (2011). Percutaneous therapy for HCC may be considered for selected patients as a bridge to hepatic transplantation, when hepatic transplantation cannot be offered due to hepatic tumor burden outside of the Milan criteria, and also when tumor resection is a risk in patients with poor hepatic reserve. The majority of features showed moderate interobserver agreement (Table 4). J. Magn. et al. [Google Scholar] However, tumor screening protocols in high risk patients can lead to an earlier detection of treatable disease. The results were interpreted as slight agreement for values of 0.010.20, fair agreement for 0.210.40, moderate agreement for 0.410.60, substantial agreement for 0.610.80, and excellent agreement for 0.810.9931. Clinical presentation Radiofrequency ablation: technique and clinical applications. TACE is recommended by multiple major liver societies as the first-line therapy for large or multifocal HCC, or in candidates with extrahepatic spread who are not suitable for surgical management (Fig. Article https://doi.org/10.1016/j.biopha.2016.10.078 (2016). Hepatocellular carcinoma is a challenging malignancy . Cancer Res. Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), wash-in, wash-out, image quality, artifacts, lesion conspicuity, and major imaging features of LI-RADS v2018 were evaluated. AJR Am. Axial single phase CT from another institution (a) shows slight irregularity of the hepatic surface, mild biliary dilatation, and trace ascites. A 50-year-old man with abdominal pain. Imaging Features of Fibrolamellar Hepatocellular Carcinoma Our own recent analysis of liver explant pathology versus prospective MRI staging of HCC demonstrated 97% sensitivity and 100% specificity for the detection of HCC. helped with designed the study, revised the manuscript critically for important intellectual content. The https:// ensures that you are connecting to the This manifests as an increased signal in the hepatic parenchyma on T1-weighted images that peaks at approximately 20 min postinjection. Several parameters such as coil geometry, phase-encoding direction, and acceleration factor can influence the noise distribution in parallel imaging. Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic